New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
202.51-11.06 (-5.18%)
At close: 04:00PM EDT
205.40 +2.89 (+1.43%)
After hours: 06:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 31.28B
Enterprise value 35.11B
Trailing P/E 21.86
Forward P/E 13.33
PEG ratio (5-yr expected) 9.07
Price/sales (ttm)2.93
Price/book (mrq)2.78
Enterprise value/revenue 3.25
Enterprise value/EBITDA 12.86

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3-41.52%
S&P500 52-week change 3-11.08%
52-week high 3372.12
52-week low 3187.16
50-day moving average 3203.08
200-day moving average 3231.54

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.32M
Shares outstanding 5146.45M
Implied shares outstanding 6N/A
Float 8146.02M
% held by insiders 10.64%
% held by institutions 186.80%
Shares short (30 May 2022) 42.41M
Short ratio (30 May 2022) 41.96
Short % of float (30 May 2022) 41.85%
Short % of shares outstanding (30 May 2022) 41.64%
Shares short (prior month 28 Apr 2022) 42.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 13.40%
Operating margin (ttm)28.59%

Management effectiveness

Return on assets (ttm)8.15%
Return on equity (ttm)14.09%

Income statement

Revenue (ttm)10.82B
Revenue per share (ttm)73.15
Quarterly revenue growth (yoy)-6.00%
Gross profit (ttm)8.87B
Net income avi to common (ttm)1.45B
Diluted EPS (ttm)9.77
Quarterly earnings growth (yoy)-25.90%

Balance sheet

Total cash (mrq)3.75B
Total cash per share (mrq)25.62
Total debt (mrq)7.59B
Total debt/equity (mrq)67.62
Current ratio (mrq)2.01
Book value per share (mrq)76.22

Cash flow statement

Operating cash flow (ttm)3.03B
Levered free cash flow (ttm)2.08B